MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2020-21)
- Udyam number
- UDYAM-HR-11-0003757
Leegaze Pharmaceuticals Private Limited
Leegaze Pharmaceuticals Private Limited - chemicals in Shahabad Markanda, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹2.41 Cr
▲ 177% YoY
Net profit · FY 2025
₹1.01 Lakh
Net margin 0.4%
EBITDA · FY 2025
₹2.07 Lakh
EBITDA margin 0.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Leegaze Pharmaceuticals Private Limited
Data last updated:
Leegaze Pharmaceuticals Private Limited is a private limited company based in Shahabad Markanda, Haryana, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 13 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24290HR2020PTC090075. Its GSTIN is 06AAECL3776D1ZK (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Aarti Devi and Sanjeev Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hno 273 Sector 1 Urban Estate, Shahabad Markanda, Haryana, India – 136135.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.41 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹1.01 Lakh (net margin 0.4%) and EBITDA of ₹2.07 Lakh (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 104% over three years.
Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
Leegaze Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-11-0003757).
Company details
CIN U24290HR2020PTC090075
Registration Number 090075
Incorporation Date 13 October 2020
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-HR-11-0003757
Key People
Aarti Devi Director Sanjeev Kumar Director Recognitions & Rankings of Leegaze Pharmaceuticals
Contact details
Leegaze Pharmaceuticals Private Limited's registered office is in Shahabad Markanda, Haryana. Its e-mail address is in the company report.
- Email
- Registered AddressHno 273 Sector 1 Urban Estate, Shahabad Markanda, Haryana, India – 136135
- IndustryChemicals, Other Chemical Product, Manufacturing
To see the full contact details of Leegaze Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Leegaze Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Leegaze Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Leegaze Pharmaceuticals Private Limited, buy the company report.
Financials of Leegaze Pharmaceuticals Private Limited
FY 2025 filings availableLeegaze Pharmaceuticals Private Limited reported revenue of ₹2.41 Cr (up 177% YoY) for FY 2025.
Revenue · FY 2025
₹2.41 Cr ▲ 177%
Net profit · FY 2025
₹1.01 Lakh margin 0.4%
EBITDA · FY 2025
₹2.07 Lakh margin 0.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 177%
3 years · compounded
▲ 104%
EBITDA CAGR growth
3 years · compounded
▲ 36%
Revenue has grown at a compounded annual rate (CAGR) of 104% over three years, including 177% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Leegaze Pharmaceuticals Private Limited, buy the company report.
Board of directors of Leegaze Pharmaceuticals Private Limited
Leegaze Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aarti Devi | Director | 30 Dec 2021 | 4 Years 10 Months | Current |
| Sanjeev Kumar | Director | 13 Oct 2020 | 6 Years 0 Months | Current |
Peer comparison
Leegaze Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Om Shubham Pharmaceuticals Private Limited | ₹2.43 Cr (FY 2024) | -23.0% | Kanpur, Uttar Pradesh, India | |||
| Medirin Pharmaceuticals Private Limited | ₹2.42 Cr (FY 2025) | 1778.0% | Ambala Cantt, Haryana, India | |||
| Leegaze Pharmaceuticals Private Limitedthis company | ₹2.41 Cr (FY 2025) | ₹1.01 Lakh | 0.4% | 177.0% | Shahabad Markanda, Haryana, India | |
| Maxicon Pharmaceuticals Private Limited | ₹2.39 Cr (FY 2024) | 58.0% | Delhi, India |
To see the full peer comparison of Leegaze Pharmaceuticals Private Limited, buy the company report.
Legal cases
Leegaze Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Total cases
2
Filed against the company
2
Pending
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Wallace Pharmaceuticals Pvt Ltd | Pending |
| Bombay High Court | Court case (CRR) | Filed against the company by Wallace Pharmaceuticals Pvt Ltd | Pending |
To see the full case history of Leegaze Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Leegaze Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Leegaze Pharmaceuticals Private Limited has 1 active EPFO establishment as of Mar 29, 2024.
Active EPFO establishments
1
GST
Leegaze Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAECL3776D1ZK | Haryana | Active | 14 Apr 2021 |
To see the full GST registrations and return filing status of Leegaze Pharmaceuticals Private Limited, buy the company report.
Recent activity
Leegaze Pharmaceuticals Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Gagandeep Singh ceased to be Director on 01 Jan 2022.
AGM
Leegaze Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Leegaze Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Ceased
Gagandeep Singh ceased to be Director.
Appointed
Aarti Devi was appointed as Director.
Appointed
Sanjeev Kumar was appointed as Director.
Incorporation
13 Oct 2020
Leegaze Pharmaceuticals Private Limited was registered on 13 Oct 2020 with Roc Haryana & aged 6 years 23 days as per MCA records.
Frequently asked questions
Leegaze Pharmaceuticals is an active private limited company based in Shahabad Markanda, Haryana, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 13 October 2020 (6+ years old) and is registered under CIN U24290HR2020PTC090075.
Leegaze Pharmaceuticals has 2 current directors:
- Aarti Devi - Director
- Sanjeev Kumar - Director
The latest financial statements of Leegaze Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Leegaze Pharmaceuticals is 06AAECL3776D1ZK, registered in Haryana.
The CIN (Corporate Identification Number) of Leegaze Pharmaceuticals is U24290HR2020PTC090075. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Leegaze Pharmaceuticals has 2 court cases on record: 2 filed against it. 2 are pending.
Leegaze Pharmaceuticals was incorporated on 13 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Leegaze Pharmaceuticals by revenue are Om Shubham Pharmaceuticals Private Limited, Medirin Pharmaceuticals Private Limited, Maxicon Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Gagandeep Singh ceased to be Director on 01 Jan 2022. Aarti Devi was appointed as Director on 30 Dec 2021. Sanjeev Kumar was appointed as Director on 13 Oct 2020.
Yes, Leegaze Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-11-0003757).
The registered office of Leegaze Pharmaceuticals is at Hno 273 Sector 1 Urban Estate, Shahabad Markanda, Haryana, India – 136135.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages